Shin J, Park H, Kim H, et al
A 2014 study showed that BPC-157 reduced methamphetamine-induced neurotoxicity in rats, preserving more normal neurons compared to the control group [14]
Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)
Singh Synthetics Quality Control "Finally, a supplier that doesn't hide behind consumer marketing
Notably, based on the results of the above-cited 15-year follow-up study, concluded in 2011, epithalamin-treatment patients had significantly lower mortality compared to the control group [12]